Cardio Diagnostics Holdings, Inc. Finite-Lived Intangible Assets, Gross
Cardio Diagnostics Holdings, Inc. (CDIO) had Finite-Lived Intangible Assets, Gross of $80.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsGross · last filed 2026-03-13
- 2025-12-31: Finite-Lived Intangible Assets, Gross $80.00K.
- 2025-09-30: Finite-Lived Intangible Assets, Gross $80.00K.
- 2025-06-30: Finite-Lived Intangible Assets, Gross $80.00K.
- 2025-03-31: Finite-Lived Intangible Assets, Gross $80.00K.
| Period end | Finite-Lived Intangible Assets, Gross | Finite-Lived Intangible Assets, Gross as first filed |
|---|---|---|
| 2025-12-31 | $80.00K 10-K · filed 2026-03-13 | |
| 2025-09-30 | $80.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $80.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $80.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $80.00K 10-K · filed 2026-03-13 | |
| 2024-09-30 | $80.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $80.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $80.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $80.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $80.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $80.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $80.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $80.00K 10-K · filed 2024-04-01 | $80.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |